Stage III Endometrial Cancer: Clinical Trials

3 trials for Stage III Endometrial Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 1 Early Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1
Phase 21Not yet recruiting 1

Follow Stage III Endometrial Cancer: new trials by email Literature Review of Stage III Endometrial Cancer trials Research Report on Stage III Endometrial Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
Biospecimen Collection, Computed Tomography, Elacestrant - Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center502026-12-182026-06-09
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Non-Interventional Study - Endometrial Carcinoma, Endometrial High Grade Endometrioid Adenocarcinoma
RecruitingMayo Clinic1002025-10-012026-11-03
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
Intensity-modulated radiation therapy, Carboplatin, Paclitaxel - Endometrial Cancer, Stage III Endometrial Cancer
Early Phase 1RecruitingMemorial Sloan Kettering Cancer Center282023-01-102026-06-25

Narrower conditions

Endometrial Neoplasms (3)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Uterine Diseases (3)  ·  Uterine Neoplasms (3)

Interventions

Carboplatin (1)  ·  Everolimus (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Paclitaxel (1)  ·  RAD1901 (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Specimen Handling (1)  ·  elacestrant (1)

Sponsors

Jonsson Comprehensive Cancer Center (1)  ·  Mayo Clinic (1)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

United States (3)

Top investigators

Evelyn A. Reynolds, MD (1)  ·  Jordyn Silverstein, MD (1)  ·  Kaled Alektair, MD (1)